Foulkes WD - Search Results

1

TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.

Greenblatt MS, Chappuis PO, Bond JP, Hamel N, Foulkes WD. Greenblatt MS, et al. Among authors: foulkes wd. Cancer Res. 2001 May 15;61(10):4092-7. Cancer Res. 2001. PMID: 11358831

2

Folate-binding protein is a marker for ovarian cancer.

Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Campbell IG, et al. Among authors: foulkes wd. Cancer Res. 1991 Oct 1;51(19):5329-38. Cancer Res. 1991. PMID: 1717147

3

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women.

Karp SE, Tonin PN, Bégin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD. Karp SE, et al. Among authors: foulkes wd. Cancer. 1997 Aug 1;80(3):435-41. doi: 10.1002/(sici)1097-0142(19970801)80:3<435::aid-cncr11>3.0.co;2-y. Cancer. 1997. PMID: 9241077

4

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

Foulkes WD, Wong N, Brunet JS, Bégin LR, Zhang JC, Martinez JJ, Rozen F, Tonin PN, Narod SA, Karp SE, Pollak MN. Foulkes WD, et al. Clin Cancer Res. 1997 Dec;3(12 Pt 1):2465-9. Clin Cancer Res. 1997. PMID: 9815648

5

Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer.

Warner E, Foulkes W, Goodwin P, Meschino W, Blondal J, Paterson C, Ozcelik H, Goss P, Allingham-Hawkins D, Hamel N, Di Prospero L, Contiga V, Serruya C, Klein M, Moslehi R, Honeyford J, Liede A, Glendon G, Brunet JS, Narod S. Warner E, et al. J Natl Cancer Inst. 1999 Jul 21;91(14):1241-7. doi: 10.1093/jnci/91.14.1241. J Natl Cancer Inst. 1999. PMID: 10413426

6

Screening for ovarian cancer.

Chappuis PO, Narod SA, Foulkes WD. Chappuis PO, et al. Among authors: foulkes wd. Lancet. 1999 Aug 7;354(9177):509-10. doi: 10.1016/S0140-6736(05)75539-2. Lancet. 1999. PMID: 10465194 Clinical Trial. No abstract available.

7

The influence of familial and hereditary factors on the prognosis of breast cancer.

Chappuis PO, Rosenblatt J, Foulkes WD. Chappuis PO, et al. Among authors: foulkes wd. Ann Oncol. 1999 Oct;10(10):1163-70. doi: 10.1023/a:1008301314812. Ann Oncol. 1999. PMID: 10586331 Free article. Review.

8

An absence of founder BRCA2 mutations in individuals with squamous cell carcinoma of the head and neck.

Hamel N, Manning A, Black MJ, Tonin PN, Foulkes WD. Hamel N, et al. Among authors: foulkes wd. Int J Cancer. 1999 Dec 10;83(6):803-4. doi: 10.1002/(sici)1097-0215(19991210)83:6<803::aid-ijc17>3.0.co;2-n. Int J Cancer. 1999. PMID: 10597198 No abstract available.

9

No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck.

Hamel N, Black MJ, Ghadirian P, Foulkes WD. Hamel N, et al. Among authors: foulkes wd. Br J Cancer. 2000 Feb;82(4):757-9. doi: 10.1054/bjoc.1999.0993. Br J Cancer. 2000. PMID: 10732740 Free PMC article.

10

Long-term outcome of invasive breast cancer.

Chappuis PO, Deschênes J, Foulkes WD. Chappuis PO, et al. Among authors: foulkes wd. Lancet. 2000 Apr 29;355(9214):1551; author reply 1552-3. doi: 10.1016/S0140-6736(00)02178-4. Lancet. 2000. PMID: 10801192 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

753 results

Search Page

Filters